Product Description
Unlock the monumental power of Rituxan, a premier therapeutic option renowned worldwide in oncology and autoimmunity. This distinguished monoclonal antibody, formulated as Rituximab 500 mg/50 ml, comes in a sterile, ready-for-dilution single-use glass vial with a secure rubber stopper. Suitable for intravenous infusion, Rituxan is FDA/EMA-approved for the treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma. Compatible with normal saline and free from preservatives, it features a clear to pale yellow appearance. Get it now from leading exporters, suppliers, and traders across India-your best-seller for reliable, safe cancer therapy.
Versatile Application and Suitable Usage
Rituximab is engineered for use in both cancer therapy and various autoimmune diseases, employing its monoclonal antibody structure for targeted action. It is suitable for adult patients under specialist care, especially those diagnosed with Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma. This medicine is used in healthcare facilities, under clinical supervision, ensuring efficacy and safety. Its application media includes intravenous infusion, making it the preferred option for precision-directed medical interventions in complex cases.
Swift Delivery and Regulatory Excellence
With quick dispatch and reliable transportation, Rituximab is supplied throughout the main domestic market with promptness and professionalism. All products arrive with complete certifications, including FDA and EMA approvals. Proposal amounts are designed to suit varied orders, ensuring flexibility for healthcare providers and institutions. Every vial is meticulously packed and shipped by certified exporters, suppliers, and traders across India, ensuring the medicine's integrity is maintained from shipping warehouse to hospital pharmacy.
FAQ's of rituximab medicine:
Q: How is Rituximab (Rituxan) typically administered?
A: Rituximab is administered as an intravenous infusion, diluted according to the manufacturer's guidelines and under the supervision of a qualified healthcare provider.
Q: What conditions can Rituximab be used to treat?
A: Rituximab is indicated for the treatment of Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, and select autoimmune diseases as prescribed by physicians.
Q: When should Rituximab not be used?
A: Rituximab is contraindicated in patients with known hypersensitivity to rituximab, murine proteins, or any component of the formulation.
Q: What are the common side effects of Rituximab?
A: Common side effects include infusion reactions, fever, chills, and increased risk of infections. All patients should be closely monitored during and after administration.
Q: Where should Rituximab be stored for optimal stability?
A: Rituximab should be stored refrigerated at 2C to 8C and should never be frozen to maintain its efficacy and shelf life.
Q: What is the process for preparing Rituximab before infusion?
A: The vial content is a lyophilized powder that should be reconstituted and diluted with 0.9% sodium chloride by a healthcare professional before intravenous infusion.